Myia

Myia Health is a digital health company that provides an enterprise-grade remote patient monitoring and predictive analytics platform. The company's technology integrates data from various sensors and wearables to monitor patients with chronic conditions, such as heart failure and COPD, in their homes. By using machine learning to identify early signs of clinical decline, Myia enables healthcare providers to intervene earlier, improving patient outcomes and reducing the cost of care. The company was acquired by Amwell in 2021 to bolster its longitudinal care capabilities. Its platform is designed to transform the management of complex patients by identifying clinical deterioration before it becomes a crisis.